further study is necessary before widespread clinical use of heparin in diabetic nephropathy. Improved knowledge of the structure-function relationship of heparin and glycosaminoglycans and a doseresponse finding of these drugs might provide a unique opportunity to select new heparin derivatives with specific effects on diabetic nephropathy and possibly, most importantly, devoid of anticoagulant activity

Letter to the editor (multiple letters)

Gambaro G.;
1998-01-01

Abstract

further study is necessary before widespread clinical use of heparin in diabetic nephropathy. Improved knowledge of the structure-function relationship of heparin and glycosaminoglycans and a doseresponse finding of these drugs might provide a unique opportunity to select new heparin derivatives with specific effects on diabetic nephropathy and possibly, most importantly, devoid of anticoagulant activity
1998
Diabetic nephropathy, heparin
File in questo prodotto:
File Dimensione Formato  
baggio1998.pdf

accesso aperto

Tipologia: Versione dell'editore
Licenza: Copyright dell'editore
Dimensione 37.07 kB
Formato Adobe PDF
37.07 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1153018
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact